In our review (Law & Morris, 1998) , we presented analyses of data from 10 cohort studies yielding the summary estimate that the risk of ischaemic heart disease was 15% lower at the 90th than at the 10th centile of fruit and vegetable consumption. This 10th ± 90th centile difference in consumption is a realistic increase for an individual (Zino et al, 1997) . The estimate of a 15% difference in heart disease mortality was similar to the expected difference in risk from the increase in potassium consumption (given the corresponding decrease in blood pressure) and the increase in folate consumption (given the corresponding decrease in plasma homocysteine) that would result from this speci®ed increase in fruit and vegetable consumption. Ness and colleagues' own approach to such a review was to tabulate the studies with their methodological details and list the result of each study as showing`no association' or protective effect' (Ness & Powles, 1997) , when the evidence did not justify the implicit dichotomy. Associations were reproduced as published, in different formats for different studies, and con®dence intervals commonly not reported. This left the reader with little impression of the average size of the association nor the degree of consistency between studies. Ness and colleagues express disapproval of our quantitative approach but provide no sound basis for rejecting it. We believe that our results are valid, and that the quanti®cation of the effect is useful in establishing for the ®rst time the moderate but important reduction in heart disease risk that results from a realistic increase in fruit and vegetable consumption.
The main argument of Ness and colleagues is that estimates of effect derived from cohort studies are unreliable. We respond to this ®rst, and then to four methodological issues that they raise.
Systematic reviews of cohort studies
Ness and his colleagues present meta-analyses of the cohort studies of dietary beta-carotene and heart disease, and of the trials of beta-carotene supplementation and heart disease, showing a signi®cant association in the cohort studies but no protective effect in the trials. This is not original, it replicates analyses that we reported in our paper (see Tables 3 and 6 ). There is no disagreement. Moreover it is well known that the trials of beta-carotene supplementation were negative. We made two conclusions. First, dietary beta-carotene is highly correlated with other constituents of fruit and vegetables, so beta-carotene is a reasonable marker of fruit and vegetable consumption even though it is not itself directly protective. Second, the observational association between beta-carotene and heart disease is no stronger than that of ®ve other markers of fruit and vegetable consumption (Table 3 in our paper), so the widely held view that beta-carotene was directly protective, discredited by the trials, had not been supported even by the observational evidence. Ness and colleagues' comments support these conclusions. The tables in our paper specify the allowances for possible confounding (these include smoking), while the social homogeneity in some of the cohorts (dentists and veterinarians, nurses, electricity company workers) minimise confounding by social class.
Quantitative assessment of the relationship between heart disease and its risk factors is best made by considering evidence from cohort studies and randomised trials together, not from either alone. Trials, as well as cohort studies, have their limitations, and the limitations of metaanalyses of randomised trials are more important than those of cohort studies because they are less widely recognised. While excluding the effects of bias and confounding, randomised trials often underestimate the effect of an intervention on mortality because their duration tends to be short when it might take years for risk to fully reverse. This was shown for the trials of serum cholesterol reduction (Law et al, 1994) ; some meta-analyses of randomised trials of serum cholesterol reduction underestimated the effect on heart disease mortality because they did not take duration into account. Cohort studies on the other hand re¯ect the effects of long-term differences in exposure (usually decades). Trials also tend to record small numbers of events so their results are imprecise. Trials and cohort studies are complementary in their strengths and weaknesses, which is why they should be considered together. We examined both types of evidence on fruit and vegetable consumption in this way, showing that the effects of potassium on blood pressure and folate on homocysteine (from trials) would together produce expected reductions in heart disease risk that are similar to the observed difference in cohort studies.
Methodological issues
Ness and colleagues raise four methodological issues, relating to heterogeneity, comprehensiveness, exclusion criteria and regression dilution. We respond to each of these in turn.
Heterogeneity
The presence of heterogeneity is not surprising. There is more variation in fruit and vegetable consumption between individuals in some study populations than in others (that is, the standard deviations differ). This introduces heterogeneity because the relative risk of heart disease could be expressed only across the population (10th to 90th centile) and not in relation to an absolute quantity of fruit and vegetables. Variation between study populations as to which speci®c fruits or vegetables are most commonly eaten will also introduce heterogeneity; there will be a stronger association with those fruits and vegetable containing more of the nutrients that are directly protective. Seasonal variation will also differ. Our summary estimates are applicable to fruit and vegetable consumption in an average population, and the statistical technique usually used to take account of such variation (DerSimonian & Laird, 1986 ) is appropriate in this context. In some situations heterogeneity may distort the average (as in the above example of randomised trials underestimating an effect because of short duration); there is no indication of such a problem here. Moreover the variation giving rise to the heterogeneity, in absolute terms, is not great (for example the variation in the size of the relative risk estimate from the six different markers of fruit and vegetable consumption ranged only between 0.81 and 0.88). Formal analyses strati®ed by such factors as the approach used to measure fruit and vegetable intake, study location, length of followup, suggested by Ness and colleagues, were irrelevant in this context. There was little variation between studies in these factors (see Table 1 in our paper Ð nearly all the studies used food frequency questionnaires for example), and it can be seen from Table 3 that the studies discrepant in any of these factors yielded similar relative risk estimates to the others.
Comprehensiveness
Ness and colleagues list ®ve sets of data that we did not include. Had we been able to include these, there is no indication that our summary result would differ. In two studies the authors focused on stroke; they reported no quantitative data on heart disease but stated that there was no association. Many of the studies included in our analysis similarly showed no signi®cant association; a 15% reduction in mortality may be dif®cult to detect in relatively small studies like these. Two studies reported associations as the relative risk of heart disease in persons who ate speci®ed fruit or vegetables commonly compared to uncommonly; quantitative data expressed in this format are inconsistent with the more frequently employed format that we used. However the relative risk estimates for speci®ed fruit and vegetables (0.76, 0.74, 0.59, 0.82, 0.59) , are (from their con®dence intervals) consistent and taken together, like our own results, suggest a worthwhile protective effect. We included data from the ®fth study (Pietinen et al, 1996) under fruit and vegetable ®bre but not under the category of total fruit and vegetable consumption, an omission on our part. However, the strength of the association was similar to that in the studies we did include.
Exclusion criteria
Potassium is a poor marker of fruit and vegetable consumption. Only a third of dietary potassium comes from fruit and vegetables (and half of this from potatoes), there is much in meat, dairy and cereal products (MAFF, 1994) . Even if potassium were a speci®c marker of fruit and vegetable consumption we would be none the wiser because the con®dence interval on the only dietary potassium study is consistent with a halving or a doubling of risk. Ness and colleagues suggest we should have excluded another study (on leucocyte vitamin C) because it too had a wide con®dence interval. We presented this study with the serum vitamin C studies (Table 4 ) and these studies together provide evidence against any substantial relationship.
Regression dilution
Many foods contain potassium: ccreals, dairy products, meat products, fruitavegetables and beverages contribute similar amounts to the diet (MAFF, 1994) . The observation that potassium consumption was not measured accurately in food frequency questionnaires is not surprising, and is not relevant to the question of how accurately people report the number of servings of fruit and vegetables they eat in a day. We agree that measures of serum carotenoids are subject to regression dilution bias and this is one reason why we made no inference from the relative risk estimate here.
Conclusions
Our summary result from the cohort studies Ð that heart disease risk is about 15% lower at the 90th than the 10th centile of fruit and vegetable consumption Ð shows a protective effect of fruit and vegetable consumption that is moderate and important. Different ways of deriving our estimate were quantitatively consistent. Ness and colleagues give no valid reason to reject our conclusion.
